Neutralizing antibodies reduce MxA protein induction in interferon- beta-1a-treated MS patients

Abstract

NAb, in most but not all cases, inhibited the in vivo function of IFNbeta. Analysis of MxA protein in lymphocytes together with analysis of NAb is a promising marker for evaluating the biologic effects of IFNbeta treatment in MS patients.